Certificate course in CRM
Cardio Renal Metabolic (CRM)
Certified by Global Health Alliance UK, UK MEDIN and London Institute of Health Sciences
Cardio Renal Metabolic Education is an initiative to promote cardio renal metabolic education globally. It brings in the best of knowledge and research on a common platform for healthcare professionals.
How to use this website:
1. The website contains modules on heart failure, diabetes and latest research in the field of CRM globally.
2. Once you have registered:
2. Once you have registered:
- You can access the modules 24/7
- Once you have completed the modules you will be able to take assessments. You will need to score 75% marks in order to pass the modules.
- Following the completion of assessment, you will be able to download the Completion Certificate.
What you will learn
Heart failure modules:
- 1. Definition, Classification, Epidemiology
- 2. Aetiology & Pathophysiology
- 3. Diagnosis & Assessment
- 4. Acute Heart Failure Management
- 5. Chronic Heart Failure Management
- 6. Device & Advanced Therapies
- 7. Guidelines & Latest News
- 1. Pathophysiology of Diabetes
- 2. Presentation, Screening and Investigations
- 3. Complications of Diabetes
- 4. Management of Diabetes
- 5. Diabetes and Cardiovascular Disease
- 1. Renal Diseases - Understanding the Physiology & Challenges in the New World
- 2. Renal Diseases - Managing the Challenges & Early Research Trials
- 1. Bariatric surgery and cardiovascular disease a systematic review and meta-analysis
- 2. Bone marrow activation in response to metabolic syndrome and early atherosclerosis
- 3. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- 4. Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
- 5. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
- 6. Effects of aspirin on dementia and cognitive function in diabetic patients the ASCEND trial
- 7. Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
- 8. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies
- 9. Polypill for prevention of cardiovascular diseases with focus on non alcoholic steatohepatitis the PolyIran Liver trial
- 10. SGLT2 inhibitors in patients with heart failure: a comprehensive meta analysis of five randomised controlled trials
Certified by:
